How Ozempic helps manage fatty liver disease Ozempic's active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...